Global Life Sciences Consulting Services Market valued at over $10 billion in 2021, is expected to grow at a decent CAGR of 10%
The life science market is evolving rapidly and is witnessing growing complexity, stringent regulations, the need for faster innovations, and the trend towards digitalization. This in turn drives the demand for pharma and biotech consulting services including drug development, regulatory affairs, scientific writing, economic affairs, quality assurance and compliance, real-world evidence solutions and pharmacovigilance (PV).
Rising Demand for Advanced
Therapies Consulting Services
Advanced therapies, such as cell and gene
therapies and personalized vaccines require specialized expertise throughout
the development, manufacturing, and regulatory process. Due to the rapidly
evolving Advanced Therapy Medicinal Products (ATMP) landscape, it’s essential to
have through knowledge and expertise to successfully develop a product and
gain a centralized market authorization (MA) in Europe and/or a Biologic
License Authorization (BLA) in USA. With rapidly expanding research on cell
and gene therapies, there is robust demand for ATMP consulting as it requires
experts with specific experience in regulatory strategy, CMC, medical communications,
and clinical development.
Product
Commercialization/Market Access – Key Element for the Success of a New Drug
Earlier,
market access for a drug depended exclusively on efficacy and safety.
However, pharmaceutical companies are now required to demonstrate
how a new drug improves patient outcomes, reduces the burden of the healthcare
system as a whole, and is it worth its price. To support these criteria's,
pharmaceutical companies are looking at a more holistic view of patient
treatment, providing better RWE and therefore a stronger value proposition for
decision-makers. Moreover, complex regulatory and reimbursement pathways,
varied evidence requirements, and long procedural timelines pose risk to
successful access and launch. All these factors are boosting the demand for
market access services including Health Economics and Outcomes Research (HEOR),
PV, and RWE strategy and consulting across the world.
Demand for Technology/IT Consulting Services Picking Up Quickly
Pharmaceutical and biotech industry is increasingly seeking technology/IT consulting services
to digitize their operations, migrate to the cloud, make use of advanced
technologies like AI/ML, and modernize existing IT infrastructures.
North America Leads the Adoption of Life Sciences Consulting Services
Market
North
America has a higher market share of global life sciences consulting services market. This is mainly attributed to the expanding biopharmaceutical industry,
significant R&D spending in the United States, the presence of leading pharmaceutical companies like J&J and Pfizer in this region, rapid adoption of digital and
IT, strict FDA regulations, and a greater focus on advanced therapies.
Competitive Landscape Analysis: Life Sciences Consulting Services Market
Explore Detailed Insights on Life Sciences Consulting Services Market Report @ https://meditechinsights.com/life-sciences-consulting-services-market/
Comments
Post a Comment